Eggplant and iMethods Expand Relationship

iMethods attains Eggplant Endorsed Service Provider status

Boulder, CO, June 26, 2019: Eggplant the intelligent test automation specialist, today announced iMethods, a leading healthcare IT solutions provider based in Jacksonville, FL, has attained status as an Eggplant Endorsed Services Provider, the highest level of partnership offered by Eggplant.

iMethods earned this designation due to its track record of implementing Eggplant for many health system partners and because it has an Eggplant-certified team of resources readily available for deployment of Eggplant’s AI-powered Digital Automation Intelligence Suite, which automates the entire testing lifecycle.

Eggplant and iMethods share a vision to help healthcare providers support patient outcomes and increase productivity. Throughout the duration of the collaboration, partner hospitals have benefited from optimized testing processes, driving the efficiency and quality of technology deliverables. This expanded relationship will enhance both Eggplant’s and iMethods’ ability to positively impact healthcare delivery in the US and improve the quality of patient care.

As an Eggplant Endorsed Services Provider, iMethods will have access to the latest products, tools, training, and support to help deliver intelligent test automation and monitoring solutions for customers.

Quotes and Commentary
“iMethods’ focus on helping healthcare organizations achieve digital maturity to deliver more coordinated care, improve patient outcomes and better prepare for a digital future make them an ideal Eggplant Endorsed Service Provider. Our Digital Automation Intelligence Suite is pivotal in delivering on our mutual business aims.”
Candice Arnold, CMO, Eggplant

“Our team at iMethods is excited about the expanded partnership with Eggplant. We have experienced tremendous feedback from our clients as they search for new ways to gain efficiencies and improve software quality. Eggplant has created products that truly advance the delivery of technology through automation. We are thrilled to be working with Eggplant to bring these advancements to the healthcare field.”
Tripp Drawdy, Vice President, Client Results

-END-

About Eggplant
Eggplant, a portfolio company of The Carlyle Group, provides user-centric, intelligent testing and performance solutions designed to optimize the digital experience, delight customers, and drive business success. Only Eggplant enables organizations to test, monitor, analyze, and report on the quality and responsiveness of software applications across different interfaces, platforms, browsers, and devices, including mobile, IoT, desktop, and mainframe. Learn more at eggplant.io.

About iMethods
Founded in 2004, iMethods is a Healthcare IT Consulting and Staffing firm that delivers a broad range of human-powered solutions to hospitals and health systems. iMethods experts are available to optimize a hospital’s operations through leadership consulting, project oversight and execution, staffing support and a host of technology services tailored to the needs of the organization. Focused on building lasting relationships, iMethods works as a trusted partner, committed to solving the IT challenges our clients face in an ever-changing healthcare landscape. Visit iMethods.com to learn more.

Contacts
UK PR (Eggplant):
Leah Jones, +44 7876 117760
ljones@thecommsco.com

US PR (Eggplant):
Claire Rowberry, +1 617-785-5571
claire@clearcommsc.com

US PR (iMethods):
Steffany Whiting, +1 336.926.1587
steffany.whiting@iMethods.com

Source: RealWire

user

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

4 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

4 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

5 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago